Hemophilia A
From DrKoop's partner site on cholesterol, CholesterolNetwork.com
Standard treatment involves replacing the missing clotting factor. The amount of factor VIII concentrates needed depend upon the severity of bleeding, the site of the bleeding, and the size of the patient. Mild hemophilia may be treated with desmopressin (DDAVP), which helps the body release factor VIII that is stored within the lining of blood vessels. To prevent a bleeding crisis, people with hemophilia and their families can be taught to give factor VIII concentrates at home at the first signs of bleeding. People with severe forms of the disease may need regular preventative treatment. advertisement
Depending on the severity of the disease, DDAVP or factor VIII concentrate may be given prior to dental extractions and surgery to prevent bleeding. Immunization with Hepatitis B vaccine is necessary because of the increased risk of exposure to hepatitis due to frequent infusions of blood products. Patients who develop an inhibitor to factor VIII may require treatment with other clotting factors such as factor VIIa, which can aide clotting even in the absence of factor VIII. Support Groups For additional resources, see hemophilia support group. Expectations (prognosis) With treatment, the outcome is good. Most people with hemophilia are able to lead relatively normal lives. A small percentage of people with hemophilia will develop inhibitors of factor VIII, and may die from loss of blood. Complications
Calling your health care provider
Review Date: 05/03/2006 ![]() | |||||||||||||||||
What's HOTGet our free newsletterPR Newswire |
|